Trial record 78 of 120 for:
Atenolol
The Impact of Heart Rate on Central Blood Pressure in Sick Sinus Syndrome Patients With a Permanent Cardiac Pacemaker
![]() |
The safety and scientific validity of this study is the responsibility of the study sponsor and investigators. Listing a study does not mean it has been evaluated by the U.S. Federal Government. Read our disclaimer for details. |
ClinicalTrials.gov Identifier: NCT03245996 |
Recruitment Status :
Completed
First Posted : August 10, 2017
Last Update Posted : July 10, 2018
|
Sponsor:
Tartu University Hospital
Information provided by (Responsible Party):
Tuuli Teeäär, Tartu University Hospital
Tracking Information | |||||
---|---|---|---|---|---|
First Submitted Date ICMJE | August 8, 2017 | ||||
First Posted Date ICMJE | August 10, 2017 | ||||
Last Update Posted Date | July 10, 2018 | ||||
Study Start Date ICMJE | June 2015 | ||||
Actual Primary Completion Date | September 2016 (Final data collection date for primary outcome measure) | ||||
Current Primary Outcome Measures ICMJE |
|
||||
Original Primary Outcome Measures ICMJE |
central systolic blood pressure [ Time Frame: 3 minutes after heart rate change ] | ||||
Change History | |||||
Current Secondary Outcome Measures ICMJE | Not Provided | ||||
Original Secondary Outcome Measures ICMJE | Not Provided | ||||
Current Other Pre-specified Outcome Measures | Not Provided | ||||
Original Other Pre-specified Outcome Measures | Not Provided | ||||
Descriptive Information | |||||
Brief Title ICMJE | The Impact of Heart Rate on Central Blood Pressure in Sick Sinus Syndrome Patients With a Permanent Cardiac Pacemaker | ||||
Official Title ICMJE | The Impact of Heart Rate on Central Hemodynamics in Sick Sinus Syndrome Patients With a Permanent Cardiac Pacemaker | ||||
Brief Summary | This study is divided into two parts:
|
||||
Detailed Description | Patients with sick sinus syndrome and a double-chamber cardiac pacemaker are studied.
|
||||
Study Type ICMJE | Interventional | ||||
Study Phase ICMJE | Phase 4 | ||||
Study Design ICMJE | Allocation: N/A Intervention Model: Single Group Assignment Masking: Single Primary Purpose: Basic Science |
||||
Condition ICMJE | Aortic Blood Pressure | ||||
Intervention ICMJE |
|
||||
Study Arms ICMJE | Experimental: Subjects
Subjects with a cardiac pacemaker
Interventions:
|
||||
Publications * |
|
||||
* Includes publications given by the data provider as well as publications identified by ClinicalTrials.gov Identifier (NCT Number) in Medline. |
|||||
Recruitment Information | |||||
Recruitment Status ICMJE | Completed | ||||
Actual Enrollment ICMJE |
27 | ||||
Original Actual Enrollment ICMJE | Same as current | ||||
Actual Study Completion Date ICMJE | September 2016 | ||||
Actual Primary Completion Date | September 2016 (Final data collection date for primary outcome measure) | ||||
Eligibility Criteria ICMJE | Inclusion Criteria:
Exclusion Criteria:
|
||||
Sex/Gender ICMJE |
|
||||
Ages ICMJE | 18 Years to 75 Years (Adult, Older Adult) | ||||
Accepts Healthy Volunteers ICMJE | No | ||||
Contacts ICMJE | Contact information is only displayed when the study is recruiting subjects | ||||
Listed Location Countries ICMJE | Not Provided | ||||
Removed Location Countries | |||||
Administrative Information | |||||
NCT Number ICMJE | NCT03245996 | ||||
Other Study ID Numbers ICMJE | 14058 | ||||
Has Data Monitoring Committee | No | ||||
U.S. FDA-regulated Product |
|
||||
IPD Sharing Statement ICMJE |
|
||||
Responsible Party | Tuuli Teeäär, Tartu University Hospital | ||||
Study Sponsor ICMJE | Tartu University Hospital | ||||
Collaborators ICMJE | Not Provided | ||||
Investigators ICMJE | Not Provided | ||||
PRS Account | Tartu University Hospital | ||||
Verification Date | July 2018 | ||||
ICMJE Data element required by the International Committee of Medical Journal Editors and the World Health Organization ICTRP |